In the last three months, 9 analysts have published ratings on Definitive Healthcare DH, offering a diverse range of perspectives from bullish to bearish.

在过去的三个月里，9位分析师发布了权威医疗卫生署的评级，提供了从看涨到看跌的多种视角。

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

下表简要介绍了他们最近的收视率，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。

Bullish

看涨

Somewhat Bullish

有点看涨

Indifferent

漠不关心

Somewhat Bearish

有点看空

Bearish

看跌

Total Ratings

总评级

2

2

0

0

6

6

1

1

0

0

Last 30D

最近30天

1

1

0

0

2

2

1

1

0

0

1M Ago

100万年前

0

0

0

0

0

0

0

0

0

0

2M Ago

200万年前

0

0

0

0

0

0

0

0

0

0

3M Ago

300万年前

1

1

0

0

4

4

0

0

0

0

Analysts have recently evaluated Definitive Healthcare and provided 12-month price targets. The average target is $7.22, accompanied by a high estimate of $9.50 and a low estimate of $5.00. Observing a downward trend, the current average is 23.52% lower than the prior average price target of $9.44. .

分析师最近评估了权威医疗保健，并提供了12个月的价格目标。。观察到下降趋势，目前的平均价格比之前的平均价格目标9.44美元低23.52%。

Investigating Analyst Ratings: An Elaborate Study

调查分析师评级：一项精心研究

In examining recent analyst actions, we gain insights into how financial experts perceive Definitive Healthcare. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

在研究最近的分析师行动时，我们深入了解了金融专家如何看待权威医疗保健。以下摘要概述了主要分析师、他们最近的评估以及对评级和价格目标的调整。

Analyst

分析员

Analyst Firm

分析公司

Action Taken

采取行动

Rating

评级

Current Price Target

当前价格目标

Prior Price Target

先前价格目标

David Grossman

大卫·格罗斯曼

Stifel

Stifel

Lowers

降低

Buy

购买

$7.50

$7.50

$9.50

$9.50

Saket Kalia

卡利亚清酒

Barclays

巴克莱银行

Lowers

降低

Equal-Weight

同等重量

$6.00

$6.00

$7.00

$7.00

Vikram Kesavabhotla

Vikram键盘地图

Baird

贝尔德

Lowers

降低

Neutral

中立

$6.00

$6.00

$8.00

$8.00

Anne Samuel

安妮·塞缪尔

JP Morgan

摩根大通

Lowers

降低

Underweight

体重不足

$5.00

$5.00

$7.00

$7.00

George Hill

乔治-希尔

Deutsche Bank

德意志银行

Lowers

降低

Hold

保持

$7.00

$7.00

$10.00

$10.00

Saket Kalia

卡利亚清酒

Barclays

巴克莱银行

Lowers

降低

Equal-Weight

同等重量

$7.00

$7.00

$11.00

$11.00

David Hynes

大卫·海因斯

Canaccord Genuity

加通贝祥

Lowers

降低

Hold

保持

$8.00

$8.00

$10.00

$10.00

David Grossman

大卫·格罗斯曼

Stifel

Stifel

Lowers

降低

Buy

购买

$9.50

$9.50

$11.00

$11.00

Craig Hettenbach

克雷格·赫滕巴赫先生

Morgan Stanley

摩根士丹利

Lowers

降低

Equal-Weight

同等重量

$9.00

$9.00

$11.50

$11.50

Key Insights:

关键见解：

Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Definitive Healthcare. This information offers a snapshot of how analysts perceive the current state of the company..

采取的行动：分析师应对市场状况和公司业绩的变化，经常更新他们的建议。无论他们是“维持”、“提高”还是“降低”自己的立场，这都反映了他们对与最终医疗保健相关的最新发展的反应。这些信息提供了分析师如何看待公司现状的快照。。

Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Definitive Healthcare compared to the broader market.

评级：获得洞察力，分析师提供定性评估，从“表现优异”到“表现不佳”。。

Price Targets: Analysts predict movements in price targets, offering estimates for Definitive Healthcare's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

价格目标：分析师预测价格目标的变动，为最终医疗保健的未来价值提供估计。检查当前和之前的目标可以洞察分析师不断变化的预期。

Capture valuable insights into Definitive Healthcare's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

通过了解这些分析师评估以及相关财务指标，获取对权威医疗保健市场地位的宝贵见解。随时了解情况，利用评级表做出战略决策。

Stay up to date on Definitive Healthcare analyst ratings.

了解权威医疗分析师的最新评级。

If you are interested in following small-cap stock news and performance you can start by tracking it here.

如果你有兴趣关注小盘股的新闻和表现，你可以从这里开始追踪。

Delving into Definitive Healthcare's Background

深入研究权威医疗保健的背景

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution.

。该公司的解决方案提供有关医疗保健提供商及其活动的准确而全面的信息，以帮助客户优化从产品开发到市场规划以及销售和营销执行的一切。

Geographically, it derives a majority of its revenue from the United States..

在地理上，它的大部分收入来自美国。。

Definitive Healthcare's Economic Impact: An Analysis

权威医疗保健的经济影响：分析

Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

市值前景：该公司的市值低于行业平均水平，表明与同行相比规模相对较小。。

Revenue Growth: Over the 3 months period, Definitive Healthcare showcased positive performance, achieving a revenue growth rate of 7.23% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers..

收入增长：在三个月的时间里，权威医疗保健公司表现出积极的表现，截至2024年3月31日，收入增长率达到7.23%。这反映了该公司收入的大幅增长。与医疗保健领域的其他公司相比，该公司表现出色，增长率高于同行的平均水平。。

Net Margin: Definitive Healthcare's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -14.99%, the company showcases strong profitability and effective cost management.

净利润率：Definitive Healthcare的财务实力反映在其异常的净利润率上，这超过了行业平均水平。该公司净利润率为-14.99%，表现出强大的盈利能力和有效的成本管理。

Return on Equity (ROE): Definitive Healthcare's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -1.11%, the company showcases efficient use of equity capital and strong financial health.

股本回报率（ROE）：确定性医疗的财务实力反映在其异常的ROE中，它超过了行业平均水平。该公司的净资产收益率为-1.11%，显示出股权资本的有效使用和强大的财务健康。

Return on Assets (ROA): Definitive Healthcare's ROA excels beyond industry benchmarks, reaching -0.52%. This signifies efficient management of assets and strong financial health.

。这意味着资产的有效管理和强大的财务健康。

Debt Management: Definitive Healthcare's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.31.

债务管理：Definitive Healthcare的债务股本比低于行业标准，表明其财务结构良好，比率为0.31。

How Are Analyst Ratings Determined?

如何确定分析师评级？

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions..

评级来自分析师或银行和金融系统内的专家，他们报告特定股票或特定行业（通常每季度一只股票）。分析师通常从公司电话会议、财务报表以及与重要内部人士的对话中获得信息，以做出决策。。

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors..

一些分析师发布了他们对增长预测、收益和收入等指标的预测，为他们的评级提供了额外的指导。在使用分析师评级时，重要的是要记住，股票和行业分析师也是人，他们只是向投资者提供意见。。

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

如果您想跟踪哪些分析师表现优于其他分析师，可以在Benzinga Pro中查看更新的分析师评级以及分析师成功分数。

This article was generated by Benzinga's automated content engine and reviewed by an editor.Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。Benzinga API为您带来的市场新闻和数据©2024 Benzinga.com。Benzinga不提供投资建议。保留所有权利。